Related Experiment Video
Updated: Sep 17, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
[Idiopathic cardiomyopathies]
Michel Komajda1, Philippe Charron
1Département de cardiologie Centre hospitalier universitaire La Pitié-La Salpêtrière 75651 Paris. michel.komajda@psl.ap-hop-paris.fr
Insights
Heart muscle diseases like dilated and hypertrophic cardiomyopathy cause significant morbidity and mortality. Genetic research is uncovering their pathophysiology, paving the way for new treatments.
Area of Science:
- Cardiology
- Genetics
- Pathophysiology
Context:
- Heart muscle diseases, including dilated and hypertrophic cardiomyopathy, present a significant health burden.
- These conditions are linked to systolic or diastolic dysfunction, leading to heart failure or sudden death.
- Dilated cardiomyopathy is a leading cause for heart transplantation, while hypertrophic cardiomyopathy is a primary cause of sudden death in athletes.
Purpose:
- To investigate the pathophysiology of heart muscle diseases using molecular genetics.
- To highlight the importance of familial screening for monogenic forms of these diseases.
- To explore the development of novel therapeutic strategies based on new genetic insights.
Summary:
- Heart muscle diseases are prevalent and morbid, often progressing to heart failure or sudden death.
- Dilated cardiomyopathy and hypertrophic cardiomyopathy are leading causes for transplantation and sudden death in athletes, respectively.
- Molecular genetics is advancing the understanding of previously idiopathic cardiomyopathies, revealing frequent familial and monogenic forms.
Impact:
- Advances in understanding the genetic basis of cardiomyopathies.
- Potential for developing targeted therapies for heart muscle diseases.
- Improved diagnostic and screening protocols for at-risk family members.
Abstract:
These heart muscle diseases, associated with systolic or diastolic dysfunction, are associated with a high prevalence and morbidity, because of the frequent evolution towards congestive heart failure or sudden death. Dilated cardiomyopathy is the first cause of heart transplantation and Hypertrophic cardiomyopathy is the first cause of sudden death in athletes. Familial and monogenic forms of these diseases are frequent and this should lead to a systematic cardiological familial inquest in first degree relatives of a patient. Although they were previously called as "idiopathic", the pathophysiology of the disease is actually under investigation thanks to molecular genetics. This completely new knowledge should lead to the development of new therapeutic strategies.
Related Concept Videos
Myocarditis I: Introduction
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

